Expression of Tie-2 by human monocytes and their responses to angiopoietin-2

Journal of Immunology

Volumn 178, Issue 11, 2007, Pages 7405-7411

  Murdoch, Craig ^a,b   Tazzyman, Simon ^a   Webster, Steve ^a   Lewis, Claire E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CD14 ANTIGEN; CD16 ANTIGEN; CD34 ANTIGEN; CHEMOATTRACTANT; CYTOKINE; FC GAMMA RECEPTOR III; FC RECEPTOR; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATION; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 34249791475     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.11.7405     Document Type: Article

References (46)

1. Murdoch, C., M. Muthana, and C. E. Lewis. 2005. Hypoxia regulates macrophage functions in inflammation. J. Immunol. 175: 6257-6263.
2. Lewis, C. E., and J. W. Pollard. 2006. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66: 605-612.
3. Lewis, C. E., and C. Murdoch. 2005. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 167: 627-635.
4. Sato, T. N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74.
5. Davis, S., T. H. Aldrich, P. F. Jones, A. Acheson, D. L. Compton, V. Jain, T. E. Ryan, J. Bruno, C. Radziejewski, P. C. Maisonpierre, and G. D. Yancopoulos. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169.
6. Maisonpierre, P. C., C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T. H. Aldrich, N. Papadopoulos, et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
7. Thurston, G., J. S. Rudge, E. Ioffe, H. Zhou, L. Ross, S. D. Croll, N. Glazer, J. Holash, D. M. McDonald, and G. D. Yancopoulos. 2000. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6: 460-463.
8. Kuroda, K., A. Sapadin, T. Shoji, R. Fleischmajer, and M. Lebwohl. 2001. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J. Invest. Dermatol. 116: 713-720.
9. Tait, C. R., and P. F. Jones. 2004. Angiopoietins in tumours: the angiogenic switch. J. Pathol. 204: 1-10.
10. Teichert-Kuliszewska, K., P. C. Maisonpierre, N. Jones, A. I. Campbell, Z. Master, M. P. Bendeck, K. Alitalo, D. J. Dumont, G. D. Yancopoulos, and D. J. Stewart. 2001. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 49: 659-670.
11. Mochizuki; Y., T. Nakamura, H. Kanetake, and S. Kanda. 2002. Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn. J. Cell Sci. 115: 175-183.
12. De Palma, M., M. A. Venneri, C. Roca, and L. Naldini. 2003. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9: 789-795.
13. De Palma, M., M. A. Venneri, R. Galli, L. S. Sergi, L. S. Politi, M. Sampaolesi, and L. Naldini. 2005. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cells 8: 211-226.
14. Zuckerman, S. H., S. K. Ackerman, and S. D. Douglas. 1979. Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology 38: 401-411.
15. Rehli, M., S. W. Krause, M. Kreutz, and R. Andreesen. 1995. Carboxypeptidase M is identical to the MAX. 1 antigen and its expression is associated with monocyte to macrophage differentiation. J. Biol. Chem. 270: 15644-15649.
16. Falk, W., R. H. Goodwin, Jr., and E. J. Leonard. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33: 239-247.
17. Sica, A., J. M. Wang, F. Colotta, E. Dejana, A. Mantovani, J. J. Oppenheim, C. G. Larsen, C. O. C. Zachariae, and K. Matsushima. 1990. Monocyte chemotactic and activating factor gene-expression induced in endothelial cells by IL-1 and tumor-necrosis factor. J. Immunol. 144: 3034-3038.
18. Lemieux, C., R. Maliba, J. Favier, J. F. Theoret, Y. Merhi, and M. G. Sirois. 2005. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 105: 1523-1530.
19. Feistritzer, C., B. A. Mosheimer, D. H. Sturn, K. Bijuklic, J. R. Patsch, and C. J. Wiedemann. 2004. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J. Allergy Clin. Immunol. 114: 1077-1084.
20. Willam, C., P. Koehne, J. S. Jurgensen, M. Grafe, K. D. Wagner, S. Bachmann, U. Frei, and K. U. Eckardt. 2000. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ. Res. 87: 370-377.
21. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
22. + blood monocytes exhibits features of tissue macrophages. Eur. J. Immunol. 23: 2053-2058.
23. Takahara, K., T. Iioka, K. Furukawa, T. Uchida, M. Nakashima, T. Tsukazaki, and H. Shindo. 2004. Autocrine/paracrine role of the angiopoietin-1 and-2/Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis. Hum. Pathol. 35: 150-158.
24. Pugh, C. W., and P. J. Ratcliffe. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9: 677-684.
25. Bosco, M. C., M. Puppo, S. Pastorino, Z. Mi, G. Melillo, S. Massazza, A. Rapisarda, and L. Varesio. 2004. Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J. Immunol. 172: 1681-1690.
26. Schioppa, T., B. Uranchimeg, A. Saccani, S. K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, et al. 2003. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198: 1391-1402.
27. Nowak, G., A. Karrar, C. Holmen, S. Nava, M. Uzunel, K. Hultenby, and S. Sumitran-Holgersson. 2004. Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 110: 3699-3707.
28. Bogdanovic, E., V. P. Nguyen, and D. J. Dumont. 2006. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J. Cell Sci. 119: 3551-3560.
29. Reusch, P., B. Barleon, K. Weindel, G. Martiny-Baron, A. Godde, G. Siemeister, and D. Marme. 2001. Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis 4: 123-131.
30. Asahara, T., T. Murohara, A. Sullivan, M. Stiver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J. M. Isner. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
31. Fernandez, P. B., F. C. Lucibello, U. M. Gehling, K. Lindemann, N. Weidner, M. L. Zuzarte, J. Adamkiewicz, H. P. Elsasser, R. Muller, and K. Havemann. 2000. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65: 287-300.
32. Schmeisser, A., C. D. Garlichs, H. Zhang, S. Eskafi, C. Graffy, J. Ludwig, R. H. Strasser, and W. G. Daniel. 2001. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiagenic conditions. Cardiovasc. Res. 49: 671-680.
33. Kuwana, M., Y. Okazaki, H. Kodama, T. Satoh, Y. Kawakami, and Y. Ikeda. 2006. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 24: 2733-2743.
34. Passlick, B., D. Flieger, and H. W. Ziegler-Heitbrock. 1989. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534.
35. Kim, I., J. H. Kim, S. O. Moon, H. J. Kwak, N. G. Kim, and G. Y. Koh. 2000. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19: 4549-4552.
36. Wefcer, C., G. Draude, K. S. Weber, J. Wubert, R. L. Lorenz, and P. C. Weber. 1999. Downregulation by tumor necrosis factor-a of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein: a potential mechanism of monocyte retention in atherosclerotic lesions. Atherosclerosis 145: 115-123.
37. Chen, J. X., Y. Chen, L. DeBusk, W. Lin, and P. C. Lin. 2004. Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesis. Am. J. Physiol. 287: H187-H195.
38. Linn, T., J. Schmitz, I. Hauck-Schmalenberger, Y. Lai, R. G. Bretzel, H. Brandhorst, and D. Brandhorst. 2006. Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clin. Exp. Immunol. 144: 179-187.
39. Ohno, S., Y. Ohno, N. Suzuki, T. Kamei, K. Koike, H. Inagawa, C. Kohchi, G.I. Soma, and M. Inoue. 2004. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res. 24: 3335-3342.
40. Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56: 4625-4629.
41. Negus, R. P., G. W. Stamp, J. Hadley, and F. R. Balkwill. 1997. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150: 1723-1734.
42. Krikun, G., F. Schatz, T. Finlay, S. Kadner, A. Mesia, R. Gerrets, and C. J. Lockwood. 2000. Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. Biochem. Biophys. Res. Commun. 275: 159-163.
43. Wang, J., K. Wu, F. Bai, H. Zhai, H. Xie, Y. Du, J. Liang, S. Han, Y. Chen, T. Lin, and D. Fan. 2006. Celecoxib could reverse the hypoxia-induced angiopoietin-2 upregulation in gastric cancer. Cancer Lett. 242: 20-27.
44. Gu, J., H. Yamamoto, M. Ogawa, C. Y. Ngan, K. Danno, H. Hemmi, N. Kyo, I. Takemasa, M. Ikeda, M. Sekimoto, and M. Monden. 2006. Hypoxia-induced up-regulation of angiopoietin-2 in colorectal cancer. Oncol. Rep. 15: 779-783.
45. Colombo, M. P., and G. Trinchieri. 2002. Iriterleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13: 155-168.
46. Voest, E. E., B. M. Kenyon, M. S. O'Reilly, G. Truitt, R. J. D'Amato, and J. Folkman. 1995. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87: 581-586.